AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HARVARD BIOSCIENCE INC Director's Dealing 2025

May 14, 2025

34975_dirs_2025-05-14_3d6d8bf4-54a7-42f3-a311-0f889535b982.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2025-05-12

Reporting Person: Frost Mark T (Interim CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-05-12	Common Stock	A	100000	$0.00	Acquired	125000	Direct

Footnotes

F1: Represents 100,000 restricted stock units that will vest on May 12, 2026.

F2: Includes (a) 100,000 restricted stock units that will vest on May 12, 2026, and (b) 25,000 shares of common stock beneficially owned by the Reporting Person.